AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $37.97
- 52-wk low
- $11.60
- Prev close
- $23.05
- Mkt cap
- $27.01B
- Beta
- 1.13
- P/S
- 3586.7x
Smart money
Earnings
Earnings landed in line with what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.6M | $2.0M | $2.5M | $1.4M |
| Cost of what it sold | $111.0K | $700.0K | $320.0K | $284.0K |
| Gross profit | $1.5M | $1.3M | $2.2M | $1.2M |
| What it spent | ||||
| Research and development | $164.6M | $165.4M | $198.9M | $202.0M |
| Sales and admin | $143.1M | $175.1M | $158.3M | $165.5M |
| Total operating expenses | $307.7M | $340.5M | $357.2M | $367.2M |
| What was left | ||||
| Operating profit | -$306.2M | -$339.2M | -$355.0M | -$366.0M |
| Profit before tax | -$159.0M | -$290.4M | $454.1M | -$294.6M |
| Tax | $7.0M | $23.3M | $98.4M | -$4.0M |
| Net profit | -$113.5M | -$265.9M | $303.0M | -$189.8M |
| EBITDA | -$158.1M | -$289.7M | $454.7M | -$288.3M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
27 articles · 7 days
Coverage is bullish
Tone of tracked coverage
Roivant Sciences (NASDAQ:ROIV) Sets New 1-Year High - Here's Why
Leans bullishAug 17Roivant Sciences stock hits all-time high at 37.06 USD By Investing.com
NeutralAug 17How Investors May Respond To Roivant Sciences (ROIV) Narrowing Losses Despite Weaker Quarterly Revenue
NeutralAug 16
